Bone marrow and pancreatic islets: An old story with new perspectives

Cell Transplantation

Volumn 19, Issue 12, 2010, Pages 1511-1522

  Ciceri, Fabio ^a   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bone marrow; Bone marrow derived cells; Diabetes; Pancreatic islets

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; THYMOCYTE ANTIBODY;

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL REGENERATION; CRYOPRESERVATION; ENDOCRINE DISEASE; FEMORAL VEIN; HEMATOPOIETIC STEM CELL; HUMAN; HYPERBARIC OXYGEN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LEUKAPHERESIS; LOW DRUG DOSE; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OLIGOSPERMIA; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; VASCULARIZATION; VEIN CATHETERIZATION;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; REGENERATION; STEM CELLS;

EID: 79951825691     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X514279     Document Type: Review

References (139)

1. Ai, C.; Todorov, I.; Slovak, M. L.; Digiusto, D.; Forman, S. J.; Shih, C. C. Human marrow-derived mesodermal progenitor cells generate insulin-secreting islet-like clusters in vivo. Stem Cells Dev. 16:757-770; 2007.
2. Akashi, T.; Shigematsu, H.; Hamamoto, Y.; Iwasaki, H.; Yatoh, S.; Bonner-Weir, S.; Akashi, K.; Weir, G. C. Bone marrow or foetal liver cells fail to induce islet regeneration in diabetic akita mice. Diabetes Metab. Res. Rev. 24:585-590; 2008.
3. Alejandro, R.; Ricordi, C.; Angelico, M. C.; Nery, J.; Webb, M.; Fernandez, L.; Lehman, R.; Karatzas, T.; Olson, L.; Tzakis, A. G. Donor bone marrow infusions in conjunction with liver-islet allotransplantation in patients with type 2 diabetes. Transplant. Proc. 29:745; 1997.
4. Alinaji; Silvers, W. K.; Bellgrau, D.; Anderson, A. O.; Plotkin, S.; Barker, C. F. Prevention of diabetes in rats by bone marrow transplantation. Ann. Surg. 194:328-338; 1981.
5. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967; 1997.
6. Banerjee, M.; Kumar, A.; Bhonde, R. R. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem. Biophys. Res. Commun. 328:318-325; 2005.
7. Barber, W. H.; Mankin, J. A.; Laskow, D. A.; Deierhoi, M. H.; Julian, B. A.; Curtis, J. J.; Diethelm, A. G. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51:70-75; 1991.
8. Beilhack, G. F.; Scheffold, Y. C.; Weissman, I. L.; Taylor, C.; Jerabek, L.; Burge, M. J.; Mas Mek, M. A.; Shizuru, J. A. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 52:59-68; 2003.
9. Bhansali, A.; Upreti, V.; Khandelwal, N.; Marwaha, N.; Gupta, V.; Sachdeva, N.; Sharma, R. R.; Saluja, K.; Dutta, P.; Walia, R.; Minz, R.; Bhadada, S.; Das, S.; Ramakrishnan, S. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev. 18:1407-1416; 2009.
10. Billingham, R. E.; Brent, L.; Medawar, P. B. 'Actively acquired tolerance' of foreign cells. 1953. J. Immunol. 184:5-8; 2010.
11. Boumaza, I.; Srinivasan, S.; Witt, W. T.; Feghali-Bostwick, C.; Dai, Y.; Garcia-Ocana, A.; Feili-Hariri, M. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J. Autoimmun. 32:33-42; 2009.
12. Brendel, M. D.; Kong, S. S.; Schachner, R. D.; Qian, T.; Selvaggi, G.; Alejandro, R.; Mintz, D. H.; Ricordi, C.; Federlin, K.; Bretzel, R. G. The influence of donor specific vertebral body derived bone marrow cell infusion on canine islet allograft survival without irradiation conditioning of the recipient. Exp. Clin. Endocrinol. Diabetes 103(Suppl. 2):129-132; 1995.
13. Britt, L. D.; Scharp, D. W.; Lacy, P. E.; Slavin, S. Transplantation of islet cells across major histocompatibility barriers after total lymphoid irradiation and infusion of allogeneic bone marrow cells. Diabetes 31(Suppl. 4):63-68; 1982.
14. Bussard, K. M.; Gay, C. V.; Mastro, A. M. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Rev. 27:41-55; 2008.
15. Butler, A. E.; Huang, A.; Rao, P. N.; Bhushan, A.; Hogan, W. J.; Rizza, R. A.; Butler, P. C. Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans. Diabetes 56:1810-1816; 2007.
16. Cantarelli, E.; Melzi, R.; Mercalli, A.; Sordi, V.; Ferrari, G.; Lederer, C. W.; Mrak, E.; Rubinacci, A.; Ponzoni, M.; Sitia, G.; Guidotti, L. G.; Bonifacio, E.; Piemonti, L. Bone marrow as an alternative site for islet transplantation. Blood 114:4566-4574; 2009.
17. Caridis, D. T.; Liegeois, A.; Barrett, I.; Monaco, A. P. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant. Proc. 5:671-674; 1973.
18. Carroll, P. B.; Fontes, P.; Rao, A. S.; Ricordi, C.; Rilo, H. L.; Zeevi, A.; Trucco, M.; Shapiro, R.; Rybka, W. B.; Scantlebury, V. Simultaneous solid organ, bone marrow, and islet allotransplantation in type I diabetic patients. Transplant. Proc. 26:3523-3524; 1994.
19. Chang, C.; Wang, X.; Niu, D.; Zhang, Z.; Zhao, H.; Gong, F. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment. Pancreas 38:275-281; 2009.
20. Chang, C. F.; Hsu, K. H.; Chiou, S. H.; Ho, L. L.; Fu, Y. S.; Hung, S. C. Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells. J. Biomed. Mater. Res. A. 86:1097-1105; 2008.
21. Chao, K. C.; Chao, K. F.; Chen, C. F.; Liu, S. H. A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters. Cell Transplant. 17:657-664; 2008.
22. Chen, L. B.; Jiang, X. B.; Yang, L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J. Gastroenterol. 10:3016-3020; 2004.
23. Choi, J. B.; Uchino, H.; Azuma, K.; Iwashita, N.; Tanaka, Y.; Mochizuki, H.; Migita, M.; Shimada, T.; Kawamori, R.; Watada, H. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 46:1366-1374; 2003.
24. Choi, K. S.; Shin, J. S.; Lee, J. J.; Kim, Y. S.; Kim, S. B.; Kim, C. W. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem. Biophys. Res. Commun. 330:1299-1305; 2005.
25. Choi, S. E.; Choi, K. M.; Yoon, I. H.; Shin, J. Y.; Kim, J. S.; Park, W. Y.; Han, D. J.; Kim, S. C.; Ahn, C.; Kim, J. Y.; Hwang, E. S.; Cha, C. Y.; Szot, G. L.; Yoon, K. H.; Park, C. G. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl. Immunol. 13:43-53; 2004.
26. Contreras, J. L.; Smyth, C. A.; Eckstein, C.; Bilbao, G.; Thompson, J. A.; Young, C. J.; Eckhoff, D. E. Peripheral mobilization of recipient bone marrow-derived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation. Surgery 134:390-398; 2003.
27. Corry, R. J.; Chakrabarti, P. K.; Shapiro, R.; Rao, A. S.; Dvorchik, I.; Jordan, M. L.; Scantlebury, V. P.; Vivas, C. A.; Fung, J. J.; Starzl, T. E. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann. Surg. 230:372-381; 1999.
28. Delis, S.; Burke, 3rd, G. W.; Ciancio, G. Bone marrow-induced tolerance in the era of pancreas and islets transplantation. Pancreas 32:1-8; 2006.
29. Ding, Y.; Xu, D.; Feng, G.; Bushell, A.; Muschel, R. J.; Wood, K. J. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes 58:1797-1806; 2009.
30. D'Ippolito, G.; Diabira, S.; Howard, G. A.; Menei, P.; Roos, B. A.; Schiller, P. C. Marrow-isolated adult multi-lineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117:2971-2981; 2004.
31. Di Santo, S.; Yang, Z.; Wyler von Ballmoos, M.; Voelzmann, J.; Diehm, N.; Baumgartner, I.; Kalka, C. Novel cell-free strategy for therapeutic angiogenesis: In vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 4:e5643; 2009.
32. Dong, Q. Y.; Chen, L.; Gao, G. Q.; Wang, L.; Song, J.; Chen, B.; Xu, Y. X.; Sun, L. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat. Clin. Invest. Med. 31:E328-337; 2008.
33. Du Toit, D. F.; Heydenrych, J. J.; Smit, B.; Zuurmond, T.; Louw, G.; Laker, L.; Els, D.; Weideman, A.; Wolfe-Coote, S.; Du Toit, L. B. The effect of ionizing radiation on the primate pancreas: An endocrine and morphologic study. J. Surg. Oncol. 34:43-52; 1987.
34. Estrada, E. J.; Valacchi, F.; Nicora, E.; Brieva, S.; Esteve, C.; Echevarria, L.; Froud, T.; Bernetti, K.; Cayetano, S. M.; Velazquez, O.; Alejandro, R.; Ricordi, C. Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant. 17:1295-1304; 2008.
35. Ezquer, F. E.; Ezquer, M. E.; Parrau, D. B.; Carpio, D.; Yanez, A. J.; Conget, P. A. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol. Blood Marrow Transplant. 14:631-640; 2008.
36. Fontes, P.; Rao, A. S.; Demetris, A. J.; Zeevi, A.; Trucco, M.; Carroll, P.; Rybka, W.; Rudert, W. A.; Ricordi, C.; Dodson, F. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344:151-155; 1994.
37. Frassoni, F.; Gualandi, F.; Podesta, M.; Raiola, A. M.; Ibatici, A.; Piaggio, G.; Sessarego, M.; Sessarego, N.; Gobbi, M.; Sacchi, N.; Labopin, M.; Bacigalupo, A. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. Lancet Oncol. 9:831-839; 2008.
38. Gao, X.; Song, L.; Shen, K.; Wang, H.; Niu, W.; Qin, X. Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. Biochem. Biophys. Res. Commun. 371:132-137; 2008.
39. Girman, P.; Kriz, J.; Dovolilova, E.; Cihalova, E.; Saudek, F. The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats. Ann. Transplant. 6:43-45; 2001.
40. Guo, Z.; Wu, T.; Sozen, H.; Pan, Y.; Heuss, N.; Kalscheuer, H.; Sutherland, D. E.; Blazar, B. R.; Hering, B. J. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice. Transplantation 75:909-915; 2003.
41. Hasegawa, Y.; Ogihara, T.; Yamada, T.; Ishigaki, Y.; Imai, J.; Uno, K.; Gao, J.; Kaneko, K.; Ishihara, H.; Sasano, H.; Nakauchi, H.; Oka, Y.; Katagiri, H. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 148:2006-2015; 2007.
42. Heeschen, C.; Lehmann, R.; Honold, J.; Assmus, B.; Aicher, A.; Walter, D. H.; Martin, H.; Zeiher, A. M.; Dimmeler, S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-1622; 2004.
43. Hess, D.; Li, L.; Martin, M.; Sakano, S.; Hill, D.; Strutt, B.; Thyssen, S.; Gray, D. A.; Bhatia, M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21:763-770; 2003.
44. Hisanaga, E.; Park, K. Y.; Yamada, S.; Hashimoto, H.; Takeuchi, T.; Mori, M.; Seno, M.; Umezawa, K.; Takei, I.; Kojima, I. A simple method to induce differentiation of murine bone marrow mesenchymal cells to insulin-producing cells using conophylline and betacellulin-delta4. Endocr. J. 55:535-543; 2008.
45. Horton, P. J.; Hawthorne, W. J.; Walters, S. N.; Patel, A. T.; O'Connell, P. J.; Chapman, J. R.; Allen, R. D. Induction of allogeneic islet tolerance in a large-animal model. Cell Transplant. 9:877-887; 2000.
46. Ianus, A.; Holz, G. G.; Theise, N. D.; Hussain, M. A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111:843-850; 2003.
47. Ikebukuro, K.; Adachi, Y.; Yamada, Y.; Fujimoto, S.; Seino, Y.; Oyaizu, H.; Hioki, K.; Ikehara, S. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats. Transplantation 73:512-518; 2002.
48. Ikehara, S.; Kawamura, M.; Takao, F.; Inaba, M.; Yasumizu, R.; Than, S.; Hisha, H.; Sugiura, K.; Koide, Y.; Yoshida, T. O. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87:8341-8344; 1990.
49. Ikehara, S.; Ohtsuki, H.; Good, R. A.; Asamoto, H.; Nakamura, T.; Sekita, K.; Muso, E.; Tochino, Y.; Ida, T.; Kuzuya, H. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 82:7743-7747; 1985.
50. Ildstad, S. T.; Sachs, D. H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168-170; 1984.
51. Izumida, Y.; Aoki, T.; Yasuda, D.; Koizumi, T.; Suganuma, C.; Saito, K.; Murai, N.; Shimizu, Y.; Hayashi, K.; Odaira, M.; Kusano, T.; Kushima, M.; Kusano, M. Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells. Biochem. Biophys. Res. Commun. 333:273-282; 2005.
52. Jabs, N.; Franklin, I.; Brenner, M. B.; Gromada, J.; Ferrara, N.; Wollheim, C. B.; Lammert, E. Reduced insulin secretion and content in VEGF-a deficient mouse pancreatic islets. Exp. Clin. Endocrinol. Diabetes 116 (Suppl. 1):S46-49; 2008.
53. Jialal, I.; Devaraj, S.; Singh, U.; Huet, B. A. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular risk. Atherosclerosis 211:297-302; 2010.
54. Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49; 2002.
55. Jin, M. X.; Engelstad, K. K.; Oluwole, S. F. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells. Transplantation 54:113-118; 1992.
56. Johansson, U.; Rasmusson, I.; Niclou, S. P.; Forslund, N.; Gustavsson, L.; Nilsson, B.; Korsgren, O.; Magnusson, P. U. Formation of composite endothelial cell-mesenchymal stem cell islets: A novel approach to promote islet revascularization. Diabetes 57:2393-2401; 2008.
57. Kahn, D.; Weiner, G. J.; Ben-Haim, S.; Ponto, L. L.; Madsen, M. T.; Bushnell, D. L.; Watkins, G. L.; Argenyi, E. A.; Hichwa, R. D. Positron emission tomographic measurement of bone marrow blood flow to the pelvis and lumbar vertebrae in young normal adults. Blood 83:958-963; 1994.
58. Kahn, D. R.; Hong, R.; Greenberg, A. J.; Gilbert, E. F.; Dacumos, G. C.; Dufek, J. H. Total lymphatic irradiation and bone marrow in human heart transplantation. Ann. Thorac. Surg. 38:169-171; 1984.
59. Kaido, T.; Yebra, M.; Cirulli, V.; Montgomery, A. M. Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1-beta1. J. Biol. Chem. 279:53762-53769; 2004.
60. Kang, E. M.; Zickler, P. P.; Burns, S.; Langemeijer, S. M.; Brenner, S.; Phang, O. A.; Patterson, N.; Harlan, D.; Tisdale, J. F. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp. Hematol. 33:699-705; 2005.
61. Karnieli, O.; Izhar-Prato, Y.; Bulvik, S.; Efrat, S. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25:2837-2844; 2007.
62. Kramp, R. C.; Congdon, C. C.; Smith, L. H. Isogeneic or allogeneic transplantation of duct-ligated pancreas in streptozotocin diabetic mice. Eur. J. Clin. Invest. 5:249-258; 1975.
63. LaFace, D. M.; Peck, A. B. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 38:894-901; 1989.
64. Lampeter, E. F.; Homberg, M.; Quabeck, K.; Schaefer, U. W.; Wernet, P.; Bertrams, J.; Grosse-Wilde, H.; Gries, F. A.; Kolb, H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243-1244; 1993.
65. Lechner, A.; Yang, Y. G.; Blacken, R. A.; Wang, L.; Nolan, A. L.; Habener, J. F. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 53:616-623; 2004.
66. Lee, R. H.; Seo, M. J.; Reger, R. L.; Spees, J. L.; Pulin, A. A.; Olson, S. D.; Prockop, D. J. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 103:17438-17443; 2006.
67. Li, F. X.; Zhu, J. W.; Tessem, J. S.; Beilke, J.; Varella-Garcia, M.; Jensen, J.; Hogan, C. J.; DeGregori, J. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc. Natl. Acad. Sci. USA 100:12935-12940; 2003.
68. Li, H.; Colson, Y. L.; Ildstad, S. T. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation 60:523-529; 1995.
69. Li, H.; Inverardi, L.; Molano, R. D.; Pileggi, A.; Ricordi, C. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Transplantation 75:966-970; 2003.
70. Li, H.; Kaufman, C. L.; Boggs, S. S.; Johnson, P. C.; Patrene, K. D.; Ildstad, S. T. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156:380-388; 1996.
71. Li, H.; Kaufman, C. L.; Ildstad, S. T. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 118:192-197; discussion 197-198; 1995.
72. Li, T. S.; Furutani, A.; Takahashi, M.; Ohshima, M.; Qin, S. L.; Kobayashi, T.; Ito, H.; Hamano, K. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 290:H1362-1369; 2006.
73. Li, Y.; Zhang, R.; Qiao, H.; Zhang, H.; Wang, Y.; Yuan, H.; Liu, Q.; Liu, D.; Chen, L.; Pei, X. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J. Cell. Physiol. 211:36-44; 2007.
74. Lin, P.; Chen, L.; Li, D.; Yang, N.; Sun, Y.; Xu, Y. Dynamic analysis of bone marrow mesenchymal stem cells migrating to pancreatic islets using coculture microfluidic chips: An accelerated migrating rate and better survival of pancreatic islets were revealed. Neuroendocrinol. Lett. 30:204-208; 2009.
75. Lu, Y.; Wang, Z.; Zhu, M. Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably. Ann. Clin. Lab. Sci. 36:127-136; 2006.
76. Luo, B.; Nanji, S. A.; Schur, C. D.; Pawlick, R. L.; Anderson, C. C.; Shapiro, A. M. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning. Transplantation 80:370-377; 2005.
77. Luo, L.; Badiavas, E.; Luo, J. Z.; Maizel, A. Allogeneic bone marrow supports human islet beta cell survival and function over six months. Biochem. Biophys. Res. Commun. 361:859-864; 2007.
78. Luo, L.; Luo, J. Z.; Xiong, F.; Abedi, M.; Greer, D. Cytokines inducing bone marrow SCA+ cells migration into pancreatic islet and conversion into insulin-positive cells in vivo. PLoS One 4:e4504; 2009.
79. Makino, S.; Kunimoto, K.; Muraoka, Y.; Mizushima, Y.; Katagiri, K.; Tochino, Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1-13; 1980.
80. Markees, T. G.; De Fazio, S. R.; Gozzo, J. J. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow. Transplantation 53:521-527; 1992.
81. Mathews, V.; Hanson, P. T.; Ford, E.; Fujita, J.; Polonsky, K. S.; Graubert, T. A. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 53:91-98; 2004.
82. McDaniel, D. O.; Naftilan, J.; Hulvey, K.; Shaneyfelt, S.; Lemons, J. A.; Lagoo-Deenadayalan, S.; Hudson, S.; Diethelm, A. G.; Barber, W. H. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 57:852-856; 1994.
83. Miller, R.; Cirulli, V.; Diaferia, G. R.; Ninniri, S.; Hardiman, G.; Torbett, B. E.; Benezra, R.; Crisa, L. Switching-on survival and repair response programs in islet transplants by bone marrow-derived vasculogenic cells. Diabetes 57:2402-2412; 2008.
84. Mineo, D.; Ricordi, C.; Xu, X.; Pileggi, A.; Garcia-Morales, R.; Khan, A.; Baidal, D. A.; Han, D.; Monroy, K.; Miller, J.; Pugliese, A.; Froud, T.; Inverardi, L.; Kenyon, N. S.; Alejandro, R. Combined islet and hematopoietic stem cell allotransplantation: A clinical pilot trial to induce chimerism and graft tolerance. Am. J. Transplant. 8:1262-1274; 2008.
85. Monaco, A. P.; Clark, A. W.; Wood, M. L.; Sahyoun, A. I.; Codish, S. D.; Brown, R. W. Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt. Surgery 79:384-392; 1976.
86. Moriscot, C.; de Fraipont, F.; Richard, M. J.; Marchand, M.; Savatier, P.; Bosco, D.; Favrot, M.; Benhamou, P. Y. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/ or microenvironmental manipulation in vitro. Stem Cells 23:594-603; 2005.
87. Naji, A.; Bellgrau, D.; Anderson, A.; Silvers, W. K.; Barker, C. F. Transplantation of islets and bone marrow cells to animals with immune insulitis. Diabetes 31 (Suppl. 4):84-91; 1982.
88. Naji, A.; Silvers, W. K.; Bellgrau, D.; Barker, C. F. Spontaneous diabetes in rats: Destruction of islets is prevented by immunological tolerance. Science 213:1390-1392; 1981.
89. Nakhooda, A. F.; Like, A. A.; Chappel, C. I.; Wei, C. N.; Marliss, E. B. The spontaneously diabetic wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome. Diabetologia 14:199-207; 1978.
90. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
91. Nelson, J. L.; Torrez, R.; Louie, F. M.; Choe, O. S.; Storb, R.; Sullivan, K. M. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. J. Rheumatol. Suppl. 48:23-29; 1997.
92. Nemeth, K.; Leelahavanichkul, A.; Yuen, P. S.; Mayer, B.; Parmelee, A.; Doi, K.; Robey, P. G.; Leelahavanichkul, K.; Koller, B. H.; Brown, J. M.; Hu, X.; Jelinek, I.; Star, R. A.; Mezey, E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15:42-49; 2009.
93. Nikolova, G.; Strilic, B.; Lammert, E. The vascular niche and its basement membrane. Trends Cell Biol. 17:19-25; 2007.
94. Oh, S. H.; Muzzonigro, T. M.; Bae, S. H.; LaPlante, J. M.; Hatch, H. M.; Petersen, B. E. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab. Invest. 84:607-617; 2004.
95. Ohshima, M.; Li, T. S.; Kubo, M.; Qin, S. L.; Hamano, K. Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells. Circ. J. 73:162-166; 2009.
96. Oikawa, A.; Siragusa, M.; Quaini, F.; Mangialardi, G.; Katare, R. G.; Caporali, A.; van Buul, J. D.; van Alphen, F. P.; Graiani, G.; Spinetti, G.; Kraenkel, N.; Prezioso, L.; Emanueli, C.; Madeddu, P. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler. Thromb. Vasc. Biol. 30:498-508; 2010.
97. Panijayanond, P.; Monaco, A. P. Enhancement of pancreatic islet allograft survival with ALS and donor bone marrow. Surg. Forum 25:379-381; 1974.
98. Park, K. S.; Kim, Y. S.; Kim, J. H.; Choi, B.; Kim, S. H.; Tan, A. H.; Lee, M. S.; Lee, M. K.; Kwon, C. H.; Joh, J. W.; Kim, S. J.; Kim, K. W. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89:509-517; 2010.
99. Phadnis, S. M.; Ghaskadbi, S. M.; Hardikar, A. A.; Bhonde, R. R. Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment. Rev. Diabet. Stud. 6:260-270; 2009.
100. Piemonti, L.; Cantarelli, E.; Nano, R.; Melzi, R.; Maffi, P.; Mercalli, A.; Sordi, V.; Ponzoni, M.; Bernardi, M.; Secchi, A.; Frassoni, F.; Doglioni, C.; Peccatori, J.; Ciceri, F. Engraftment of pancreatic islets in bone marrow: Preclinical evaluation and pilot clinical experience. Bone Marrow Transpl. 45(Suppl. 2):S65; 2010.
101. Posselt, A. M.; Odorico, J. S.; Barker, C. F.; Naji, A. Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone marrow. Diabetes 41:771-775; 1992.
102. Rao, A. S.; Fontes, P.; Zeevi, A.; Trucco, M.; Dodson, F. S.; Rybka, W. B.; Shapiro, R.; Jordan, M.; Pham, S. M.; Rilo, H. L. Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant. Proc. 27:210-212; 1995.
103. Rao, A. S.; Fontes, P.; Zeevi, A.; Trucco, M.; Shapiro, R.; Demetris, A. J.; Tzakis, A. G.; Carroll, P. B.; Rudert, W. A.; Dodson, F. S. Combined bone marrow and whole organ transplantation from the same donor. Transplant. Proc. 26:3377-3378; 1994.
104. Ricordi, C.; Murase, N.; Rastellini, C.; Behboo, R.; Demetris, A. J.; Starzl, T. E. Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. Transplant. Proc. 26:3358; 1994.
105. Ricordi, C.; Murase, N.; Rastellini, C.; Behboo, R.; Demetris, A. J.; Starzl, T. E. Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation. Cell Transplant. 5:53-55; 1996.
106. Rolles, K.; Burroughs, A. K.; Davidson, B. R.; Karatapanis, S.; Prentice, H. G.; Hamon, M. D. Donor-specific bone marrow infusion after orthotopic liver transplantation. Lancet 343:263-265; 1994.
107. Sakata, N.; Chan, N. K.; Chrisler, J.; Obenaus, A.; Hathout, E. Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation 89:686-693; 2010.
108. Salazar-Banuelos, A.; Wright, J.; Sigalet, D.; Benitez-Bribiesca, L. The bone marrow as a potential receptor site for pancreatic islet grafts. Arch. Med. Res. 39:139-141; 2008.
109. Schlitt, H. J.; Hundrieser, J.; Hisanaga, M.; Uthoff, K.; Karck, M.; Wahlers, T.; Wonigeit, K.; Pichlmayr, R. Patterns of donor-type microchimerism after heart transplantation. Lancet 343:1469-1471; 1994.
110. Serreze, D. V.; Leiter, E. H.; Worthen, S. M.; Shultz, ven-namesL. D. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON)F1 mice. Diabetes 37:252-255; 1988.
111. Seung, E.; Iwakoshi, N.; Woda, B. A.; Markees, T. G.; Mordes, J. P.; Rossini, A. A.; Greiner, D. L. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 95:2175-2182; 2000.
112. Shimada, T.; Takeshita, Y.; Murohara, T.; Sasaki, K.; Egami, K.; Shintani, S.; Katsuda, Y.; Ikeda, H.; Nabeshima, Y.; Imaizumi, T. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110:1148-1155; 2004.
113. Slavin, S.; Nagler, A.; Naparstek, E.; Kapelushnik, Y.; Aker, M.; Cividalli, G.; Varadi, G.; Kirschbaum, M.; Ackerstein, A.; Samuel, S.; Amar, A.; Brautbar, C.; Ben-Tal, O.; Eldor, A.; Or, R. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756-763; 1998.
114. Slavin, S.; Strober, S.; Fuks, Z.; Kaplan, H. S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J. Exp. Med. 146:34-48; 1977.
115. Solari, M. G.; Srinivasan, S.; Boumaza, I.; Unadkat, J.; Harb, G.; Garcia-Ocana, A.; Feili-Hariri, M. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. J. Autoimmun. 32:116-124; 2009.
116. Sordi, V.; Malosio, M. L.; Marchesi, F.; Mercalli, A.; Melzi, R.; Giordano, T.; Belmonte, N.; Ferrari, G.; Leone, B. E.; Bertuzzi, F.; Zerbini, G.; Allavena, P.; Bonifacio, E.; Piemonti, L. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419-427; 2005.
117. Sordi, V.; Melzi, R.; Mercalli, A.; Formicola, R.; Doglioni, C.; Tiboni, F.; Ferrari, G.; Nano, R.; Chwalek, K.; Lammert, E.; Bonifacio, E.; Piemonti, L. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells 28:140-151; 2010.
118. Starzl, T. E.; Demetris, A. J.; Trucco, M.; Ramos, H.; Zeevi, A.; Rudert, W. A.; Kocova, M.; Ricordi, C.; Ildstad, S.; Murase, N. Systemic chimerism in human female recipients of male livers. Lancet 340:876-877; 1992.
119. Starzl, T. E.; Demetris, A. J.; Trucco, M.; Zeevi, A.; Ramos, H.; Terasaki, P.; Rudert, W. A.; Kocova, M.; Ricordi, C.; Ildstad, S. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55:1272-1277; 1993.
120. Sun, J.; Yang, Y.; Wang, X.; Song, J.; Jia, Y. Expression of pdx-1 in bone marrow mesenchymal stem cells promotes differentiation of islet-like cells in vitro. Sci. China C Life Sci. 49:480-489; 2006.
121. Sun, Y.; Chen, L.; Hou, X. G.; Hou, W. K.; Dong, J. J.; Sun, L.; Tang, K. X.; Wang, B.; Song, J.; Li, H.; Wang, K. X. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin. Med. J. (Engl.) 120:771-776; 2007.
122. Sykes, M. Mechanisms of tolerance induced via mixed chimerism. Front. Biosci. 12:2922-2934; 2007.
123. Tamarat, R.; Silvestre, J. S.; Le Ricousse-Roussanne, S.; Barateau, V.; Lecomte-Raclet, L.; Clergue, M.; Duriez, M.; Tobelem, G.; Levy, B. I. Impairment in ischemia-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol. 164:457-466; 2004.
124. Tang, D. Q.; Cao, L. Z.; Burkhardt, B. R.; Xia, C. Q.; Litherland, S. A.; Atkinson, M. A.; Yang, L. J. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53:1721-1732; 2004.
125. Tayaramma, T.; Ma, B.; Rohde, M.; Mayer, H. Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells. Stem Cells 24:2858-2867; 2006.
126. Than, S.; Ishida, H.; Inaba, M.; Fukuba, Y.; Seino, Y.; Adachi, M.; Imura, H.; Ikehara, S. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-ay mice. J. Exp. Med. 176:1233-1238; 1992.
127. Thum, T.; Fraccarollo, D.; Schultheiss, M.; Froese, S.; Galuppo, P.; Widder, J. D.; Tsikas, D.; Ertl, G.; Bauersachs, J. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56:666-674; 2007.
128. Urban, V. S.; Kiss, J.; Kovacs, J.; Gocza, E.; Vas, V.; Monostori, E.; Uher, F. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26:244-253; 2008.
129. Voltarelli, J. C.; Couri, C. E.; Stracieri, A. B.; Oliveira, M. C.; Moraes, D. A.; Pieroni, F.; Coutinho, M.; Malmegrim, K. C.; Foss-Freitas, M. C.; Simoes, B. P.; Foss, M. C.; Squiers, E.; Burt, R. K. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297:1568-1576; 2007.
130. Wicker, L. S.; Miller, B. J.; Chai, A.; Terada, M.; Mullen, Y. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD x B10) F1 mice with bone marrow cells from NOD mice. J. Exp. Med. 167:1801-1810; 1988.
131. Wu, T.; Levay-Young, B.; Heuss, N.; Sozen, H.; Kirchhof, N.; Sutherland, D. E.; Hering, B.; Guo, Z. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 74:22-27; 2002.
132. Wu, X. H.; Liu, C. P.; Xu, K. F.; Mao, X. D.; Zhu, J.; Jiang, J. J.; Cui, D.; Zhang, M.; Xu, Y.; Liu, C. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J. Gastroenterol. 13:3342-3349; 2007.
133. Xie, Q. P.; Huang, H.; Xu, B.; Dong, X.; Gao, S. L.; Zhang, B.; Wu, Y. L.
134. Yasumizu, R.; Sugiura, K.; Iwai, H.; Inaba, M.; Makino, S.; Ida, T.; Imura, H.; Hamashima, Y.; Good, R. A.; Ikehara, S. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc. Natl. Acad. Sci. USA 84:6555-6557; 1987.
135. Zanone, M. M.; Favaro, E.; Camussi, G. From endothelial to beta cells: Insights into pancreatic islet microendothelium. Curr. Diabetes Rev. 4:1-9; 2008.
136. Zhang, C.; Todorov, I.; Lin, C. L.; Atkinson, M.; Kandeel, F.; Forman, S.; Zeng, D. Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proc. Natl. Acad. Sci. USA 104:2337-2342; 2007.
137. Zhao, M.; Amiel, S. A.; Ajami, S.; Jiang, J.; Rela, M.; Heaton, N.; Huang, G. C. Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells. PLoS One 3:e2666; 2008.
138. Zhao, S.; Wehner, R.; Bornhauser, M.; Wassmuth, R.; Bachmann, M.; Schmitz, M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev. 19:607-614; 2010.
139. Zorina, T. D.; Subbotin, V. M.; Bertera, S.; Alexander, A. M.; Haluszczak, C.; Gambrell, B.; Bottino, R.; Styche, A. J.; Trucco, M. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21:377-388; 2003.